Hepatocellular Carcinoma - Current Aspects of Screening, Surveillance and Therapeutic Strategies (Revised EASL-EORTC Recommendations)

被引：3

作者：

Roeb, E. ^{[1
]}

机构：

[1] Univ Giessen Klinikum, Med Klin & Poliklin 2, D-35392 Giessen, Germany

来源：

ZENTRALBLATT FUR CHIRURGIE | 2014年 / 139卷 / 02期

关键词：

hepatocellular carcinoma; liver tumour; multimodal treatment; CHRONIC HEPATITIS-C; GROWTH-FACTOR GENE; CIRRHOTIC-PATIENTS; COST-EFFECTIVENESS; RISK-FACTORS; FUNCTIONAL POLYMORPHISM; RADIOFREQUENCY ABLATION; CANCER STATISTICS; LIVER; VIRUS;

D O I：

10.1055/s-0033-1350669

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

With an incidence of 523000 new cases a year hepatocellular carcinomas (HCCs) belong to the most frequent cancer entities worldwide. Diagnostic and therapeutic procederes have been improved during the last years. Surveillance of patients with high risk factors leads to an early diagnosis. Up to now the detection of early HCCs represents the best prerequisite for any curative therapy. The present synopsis summarises the current guidelines of the European Association for the Study of the Liver (EASL) and the European Organisation for Research and Treatment of Cancer (EORTC) with a special focus on screening and surveillance of risk groups.

引用

页码：175 / 183

页数：9

共 58 条

[1] A Functional Polymorphism in the Epidermal Growth Factor Gene Is Associated With Risk for Hepatocellular Carcinoma [J].

Abu Dayyeh, Barham K. ;

Yang, May ;

Fuchs, Bryan C. ;

Karl, Daniel L. ;

Yamada, Suguru ;

Sninsky, John J. ;

O'Brien, Thomas R. ;

Dienstag, Jules L. ;

Tanabe, Kenneth K. ;

Chung, Raymond T. .

GASTROENTEROLOGY, 2011, 141 (01) :141-149

[2]

Arguedas MR, 2003, AM J GASTROENTEROL, V98, P679, DOI 10.1111/j.1572-0241.2003.07327.x

[3] Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelines [J].

Barreiros, Ana Paula ;

Piscaglia, Fabio ;

Dietrich, Christoph F. .

JOURNAL OF HEPATOLOGY, 2012, 57 (04) :930-932

[4] Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma [J].

Bolondi, L ;

Gaiani, S ;

Celli, N ;

Goffieri, R ;

Grigioni, WF ;

Leoni, S ;

Venturi, AM ;

Piscaglia, F .

HEPATOLOGY, 2005, 42 (01) :27-34

[5] Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis [J].

Bolondi, L ;

Sofia, S ;

Siringo, S ;

Gaiani, S ;

Casali, A ;

Zironi, G ;

Piscaglia, F ;

Gramantieri, L ;

Zanetti, M ;

Sherman, M .

GUT, 2001, 48 (02) :251-259

[6] Screening for hepatocellular carcinoma in cirrhosis [J].

Bolondi, L .

JOURNAL OF HEPATOLOGY, 2003, 39 (06) :1076-1084

[7] Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004 [J].

Bosetti, Cristina ;

Levi, Fabio ;

Boffetta, Paolo ;

Lucchini, Franca ;

Negri, Eva ;

La Vecchia, Carlo .

HEPATOLOGY, 2008, 48 (01) :137-145

[8] Management of Hepatocellular Carcinoma: An Update [J].

Bruix, Jordi ;

Sherman, Morris .

HEPATOLOGY, 2011, 53 (03) :1020-1022

[9] Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis:: A retrospective study [J].

Bruno, Savino ;

Stroffolini, Tommaso ;

Colombo, Massimo ;

Bollani, Simona ;

Benvegnu, Luisa ;

Mazzella, Giuseppe ;

Ascione, Antonio ;

Santantonio, Teresa ;

Piccinino, Felice ;

Andreone, Pietro ;

Mangia, Alessandra ;

Gaeta, Giovanni B. ;

Persico, Marcello ;

Fagiuoli, Stefano ;

Almasio, Piero L. .

HEPATOLOGY, 2007, 45 (03) :579-587

[10] Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study [J].

Chang, Mei-Hwei ;

You, San-Lin ;

Chen, Chien-Jen ;

Liu, Chun-Jen ;

Lee, Chuan-Mo ;

Lin, Shi-Ming ;

Chu, Heng-Cheng ;

Wu, Tzee-Chung ;

Yang, Sheng-Shun ;

Kuo, Hsu-Sung ;

Chen, Ding-Shinn .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (19) :1348-1355

← 1 2 3 4 5 6 →